CU6 1.41% $6.46 clarity pharmaceuticals ltd

Ann: First patient dosed in Phase III prostate cancer trial, page-13

  1. 2,489 Posts.
    lightbulb Created with Sketch. 503
    Indeed.

    No better feeling than the regret of making a nice profit at the end of the day when you failed to have the courage of your convictions at the start is there?
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.